A n S T R A C T A radioimmunoassay for detection of anti-glomerular basement membrane (GBM) antibody was set up with a 70,000 mol wt GBM antigen, labeled with Iodine-'I and containing both types of oligosaccharidic chains present in the whole membrane.
INTRODUCTION
It is generally admitted that anti-glomerular basement membrane (GBM)' antibodies are involved in the pathogenesis of some cases of human and experimental glomerulonephritis (GN) (1) (2) (3) . Several techniques have been used to study anti-GBM immunity in animals and in man. Immunofluorescence can be performed directly on glomerulonephritic kidneys or after transfer of circulating or eluted anti-GBM antibodies onto normal kidney slices (1) (2) (3) (4) (5) . The existence of anti-GBM antibodies is then suggested by the presence of linear deposits along the GBM (1) (2) (3) (4) (5) . Agar gel precipitation and passive hemagglutination tests have also been used in experimental (3) or in human (1, 6 ) GN for the detection of circulating anti-GBM antibodies. Recently, the leukocyte migration inhibition test has been applied to human GN, by the two-step (7) or the one-step method (6) , in order to study cell-mediated anti-GBM immunity.
In this work, a direct binding test is described for detection of anti-GBM antibodies. The method is based on the fact that most of the immunoglobulin molecules are precipitated in 20% polyethylene glycol (PEG) solutions, while smaller antigens, like bovine serum albumin (BSA) remain soluble at this PEG concentration (8) .
GBM antigens, with an average mol wt of 70,000, containing both types of oligosaccharide chains, have been purified from solubilized GBM (9) . Anti-GBM 1Abbreviations used in this paper: Ag, antigen; BSA, bovine serum albumin; GBM, glomerular basement membrane; GN, glomerulonephritis; NHS, normal human serum; NRS, normal rabbit serum; PEG, polyethylene glycol.
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antibodies were detected by using a technique similar to the Farr antigen binding test (10) ; however, a 20% PEG solution was used instead of ammonium sulfate in order to separate free GBM antigens from those bound to immunoglobulins, because these antigens remain soluble at this PEG concentration. The specificity and the avidity of rabbit and human anti-GBM antibodies for human GBM antigens have also been investigated. Finally, anti-GBM antibodies were sought in the serum of 300 normal blood donors and of 134 patients with various nephropathies. METHODS
Buffer. All serum dilutions or PEG solutions were made in borate buffer, ionic strength 0.1, pH 8.3-8. 5 .
Antigens. GBM were isolated from normal human kidneys obtained from autopsies, according to the method of Krakower and Greenspon (11) . The morphological and biochemical criteria of purity were previously described (12) . The GBM were solubilized by autoclaving a suspenson of membranes at 1100C for 3 h, in Tris-acetate buffer 0.1 M, pH 7.4 (9) . GBM components, all of which contain both types of oligosaccharide chains, were isolated from the solubilized material by affinity chromatography and preparative polyacrylamide electrophoresis, in the presence of sodium dodecylsulfate. Their mol wt ranged from 70,000 to more than 300,000 (9) . A soluble GBM fraction with an average mol wt of 70,000 was selected for radioimmunological studies (Fig. 1) .
Glycopeptides containing either the disaccharide or heteropolysaccharide chains were isolated, after enzymatic digestion of GBM with pronase and collagenase, by gel filtration, ion exchange chromatography, and preparative paper electrophoresis (13, 14) . Neutral sugars, hexosamines, and sialic acid were measured by previously described techniques (12, 14) ; amino-acid composition was determined in a Beckman model Unichrom amino-acid analyzer (Beckman Instruments, Inc., Fullerton, Calif.) (11) . The protein content was measured by the method of Lowry, Rosebrough, Farr, and Randall, with BSA as a standard (15) and the glycopeptide concentration by the ninhydrin reaction with leucine as a standard (16 (9) . The carbohydrate and aminoacid composition of the proteins eluted with acidic buffer (9) was determined as previously described (12, 14) . The molecular weight of labeled and unlabeled antigens eluted with the same buffer was evaluated by acrylamide disc gel electrophoresis in dodecylsulfate (9) . Before running, the samples were incubated with 4% sodium dodecylsulfate and 0.1 M mercaptoethanol for 1 h at 60'C. The proteins were stained with coomassie blue; the gels were also sliced and the radioactivity of gel slices (0.4 cm in thickness) was counted in a double channel Picker nuclear spectrometer (Picker Corp., Cleveland, Ohio). (Fig. 1) . The amino acid composition of GBM antigens purified by affinity chromatography is given in Table III . It should be stressed that this glycopeptide contained glucose, galactose, and hydroxylysine in equimolecular amounts. 2 The carbohydrate and amino acid composition of the tested heteropolysaccharide-containing glycopeptide is given in Table IV . Aspartic acid, threonine, serine, glutamic acid, proline, glycine, and alanine were the most abundant amino acids of this glycopeptide. The heteropolysaccharide chain was formed of fucose, hexosamines, mannose, galactose, and sialic acid. No hydroxylysine or glucose were found.
Detection of rabbit anti-human GBM antibodies. The solubility of labeled membrane antigens was studied in the presence of various PEG concentrations. It was found that the addition of 0.5 ml of 40% PEG to 10 ng 10 (A-A) . 10 ng of labeled GBM Ag were mixed with 0.4 ml of the various diluted sera, then with 0.5 ml of the different PEG solutions. After an incubation at 4VC overnight, the precipitates obtained by centrifugation at 1,000 g were washed twice with the PEG solution at the final concentration used in the mixture; the radioactivity was counted in a Picker Nuclear Spectrometer.
active antigens are specifically precipitated. Examples of such titration curves, obtained with either whole rabbit anti-serum or purified rabbit anti-GBM IgG, are given in Fig. 3 . In these cases, the anti-GBM antibody titers averaged 10' and 6.104, respectively.
Detection of anti-GBM antibodies in sera and kidney eluate from a patient with a Goodpasture's syndrome. As in NRS, the nonspecific precipitation of [MI]GBM Ag in NHS was lower than 20%, with 20% PEG. However, in the presence of a similarity diluted serum of the patient with severe Goodpasture's syndrome, 43% of the same antigens were precipitated (Fig. 2) Titration of human antibodies to GBM antigens was therefore performed by precipitation of immunoglobulin-bound antigens with PEG at a final concentration of 20%. Examples of titration curves obtained either with anti-GBM serum or with eluted anti-GBM antibodies are given in Fig. 3 . With the same IgG concentration, it was shown that the anti-GBM antibody titer was higher with eluted than with circulating IgG. The precipitation of ['I]GBM Ag was followed in 16 sera of the same patient obtained before and after bilateral nephrectomy. A significant increase of the precipitation was observed immediately after the bilateral nephrectomy with a maximal value of specific precipitation of 42%.
Specificity and avidity of human and rabbit anti-GBM antibodies for membrane antigens. To control the specificity of the radioimmunoassay, rabbit anti-whole human serum or anti-Clq antibodies were incubated with ['I]GBM Ag. No significant specific precipitation was observed. Inhibition experiments were then performed. Increasing amounts (20-100 ng) of unlabeled GBM antigens, human procollagen, Clq, or streptococcal cell membrane antigens were added to a solution of human anti-GBM antibodies binding specifically 20% of [HI] GBM Ag. 100 ng of unlabeled GBM antigens strongly inhibited the binding of 10 ng of radioactive antigens with anti-GBM antibodies, while 100 ng of procollagen, Clq, or streptococcal antigens slightly reduced the specific precipitation (Fig. 4) . Increasing amounts of both types of GBM glycopeptides were also added to a similar solution of human anti-GBM antibodies eluted from the kidneys of a patient with Goodpasture's syndrome. Whereas 100 ng of the disaccharidecontaining glycopeptide inhibited 60% of the binding of labeled GBM antigens with anti-GBM antibodies, 1 Ag of cold GBM antigen was then added to the mixture, and after 5 min, 1, or 4 h, the immunoglobulin-bound antigens were precipitated with 0.5 ml of 40% PEG. Control experiments were performed by the same experimental methodology, but borate buffer was added to the mixture instead of cold GBM Ag. Fig. 6 shows that the dissociation rate of human GBM-anti-GBM antibody complexes was much faster than that of rabbit GBM-anti-GBM antibody complexes. These results are probably representative of the difference of avidity between human and rabbit anti-GBM antibodies for GBM antigens.
Reproducibility and sensitivity of the GBM radioimmunoassay. Anti-GBM antibody levels in nephropathies. After correction for the non-specificprecipitationof ['I]GBM Ag obtained in a pool of 92 normal blood donor's sera, the percentage of labeled GBM Ag precipitated in the serum of 300 normal blood donors was 0.3±3.2%. It has been arbitrarily considered that patients with at least 10% of labeled GBM Ag precipitated exhibited a significant anti-GBM activity in their serum. Results of anti-GBM antibody levels in nephropathies are given in Fig. 7 .
It should be stressed that (a) most of the patients with GN and linear deposits exhibited high anti-GBM antibody titers in their serum; only one patient with polyarteritis nodosa and one with rapidly progressive GN exhibited negative results; (b) 8.3% of patients with GN and granular deposits presented significant, but lower, anti-GBM activity in their serum; amongst these patients with positive binding, two presented 100- ['I]GBM Ag (10 ng) was mixed with 0.4 ml of tested sera for 90 min at 37°C; then 1 jug of cold GBM Ag was added, and after 5 min., or 1 or 4 h, the GBM-anti-GBM antibody complexes were precipitated with 0.5 ml of 40% PEG. In control experiments, the same procedure was used, but borate buffer was added to the mixture instead of cold GBM Ag.
Radioimmunoassay for Anti-Glmerar Basement Membrane Antibodies membrano-proliferative GN, two presented focal GN with extracapillary proliferation, three endo-and extracapillary proliferative GN, and the three others lupus nephritis; (c) all patients with non-proliferative GN exhibited negative results. In four of these "positive" patients, IgG fractions were isolated from serum and were shown to contain a significant binding activity. DISCUSSION It is well known (24, 25) that GBM are mostly glycoproteins containing two different oligosaccharidic chains; one is a disaccharide formed of equimolecular amounts of glucose and galactose, while the other is a heteropolysaccharide composed of 'mannose, fucose, galactose, sialic acid, and hexosamines (13, 14) . However, the basement membrane structure responsible for the production of anti-GBM antibodies remains a matter of controversy. GBM contains at least three major antigenic components: one of these components is the "collagenlike" material with the disaccharide chains, while the two others, differing in their molecular weights, contain the heteropolysaccharide units (26) . A first group of investigators, using fractions of collagenase or tryptic digests of GBM, have induced nephrotoxic antibodies into heterologous species (27, 28) ; these fractions contain the sialoprotein material of the GBM (27) or do not appear related to the collagen-like material, as they contain high amounts of glucose and galactose but lack hydroxylysine (28) . Moreover, these latter fractions, of relatively high molecular weight, exhibit large amounts of glycine residues without hydroxyproline (28) . Other investigators (29) , using antibodies eluted from kidneys of a patient with Goodpasture's syndrome, suggest that the collagen-like glycoproteins are indeed the antigens responsible for -this autoimmune GN. These discrepancies justify the choice of GBM antigens containing both types of oligosaccharide chains for radioimmunoassay. The 70,000 mol wt fraction obtained by heating basement membrane to 1100C does not necessarily represent an intact structural subunit of the whole GBM; it might result from the cleavage of one or more covalent bonds. However, since these antigens have been isolated from GBM glycoproteins by affinity chromatography, using Sepharose cyanogen bromide coupled with specific rabbit anti-human GBM IgG (9), one may assume that they contain some of the major antigenic determinants of the whole GBM structure, regardless of the fact that these antigenic determinants may be present on either a continuous or an adjacent peptide chain. In this work, it was shown that a synthetic polymer, PEG, could be used in a direct binding test for detection of circulating anti-GBM antibodies; the addition of this polymer to the reaction medium is used to exclude from the solvent most of the immunoglobulin molecules and GBM antigen bound to immunoglobulins, while the GBM antigen could not be excluded in a free form. The mechanism of action of PEG is not known, but might be similar to that of dextran on the precipitation of immune complexes, i.e., a steric exclusion of the antigen-antibody complexes from the domain of the polymer (30) . The principle of the PEG technique used is therefore similar to that used for the antigen binding test previously described by Farr (10 (17) , and procollagen do not inhibit the specific precipitation of GBM-anti-GBM antibody complexes in the presence of 20% PEG. The specificity of 'P. Mahieu, and P. H. Lambert. Unpublished data.
anti-GBM antibodies has been further investigated in one case of Goodpasture's syndrome. It has been shown that the disaccharide-containing glycopeptide inhibits more efficiently the binding of anti-GBM antibodies with GBM antigens than does the heteropolysaccharidecontaining glycopeptide. Similar data have been recently obtained with anti-GBM antibodies found in the serum of seven patients with GN and linear deposits of immunoglobulins (23) . Cross-antigenicity between GBM and streptococcal cell membranes has been reported (31) . Such cross-reactions have not been observed by radioimmunoassay with the antisera available and in presence of a 10-fold antigen excess. It has been demonstrated by the direct binding test that anti-GBM antibodies can be detected in the serum or in IgG fractions from immunized rabbits, and in sera IgG fractions or kidney eluate from Goodpasture's syndrome. In the best conditions, the specific precipitation of ['I]GBM Ag obtained with human anti-GBM antibodies was 42% and was therefore not as high as for rabbit anti-human GBM antibodies. Several facts could explain this difference: (a) the absolute anti-GBM antibody concentration in the serum of rabbits immunized with heterologous GBM is much higher than that in the serum of human autoimmune GN. These low human anti-GBM antibody titers could be due to the fixation of antibodies on the "target" organ. The increase in
[HI] GBM Ag precipitated immediately after the bilateral nephrectomy of the Goodpasture's syndrome patient is in agreement with such a hypothesis and confirms similar observations of other workers (1, 32); (b) GBM are very complex glycoproteic structures and therefore the GBM antigens used might not involve all the antigenic determinants of the whole GBM, despite the fact that these antigens have been purified by affinity chromatography with anti-whole human GBM IgG; (c) the avidity of human anti-GBM antibodies for GBM antigens is lower than that of rabbit anti-human GBM antibodies. The difference in the dissociation rate between rabbit and human GBM-anti-GBM antibody complexes supports this explanation; (d) GBM antigens eventually present in circulating blood could interfere with the binding of labeled GBM antigens with anti-GBM antibodies. The demonstration of GBM crossreactive antigens in normal human serum or urine is in agreement with this hypothesis (32, 33) .
Preliminary results obtained with patients exhibiting various nephropathies are of interest. Indeed, most of the patients with GN and linear deposits of immunoglobulins present high GBM binding activity in their serum. McPhaul and Dixon (32) have demonstrated that only 40% of people known to have anti-GBM antibody-mediated GN were shown to exhibit circulating anti-GBM antibodies by indirect immunofluorescence.
By radioimmunoassay, only 2 out of 14 patients with GN and linear deposits did not present circulating anti-GBM antibody. These two negative results could be explained by the fact that some extramembranous immune complex deposits may give a false linear pattern of immunofluorescence (34) . Nonspecific binding of ['I]-GBM Ag on molecules other than immunoglobulins is unlikely to occur, since IgG fractions purified from positive sera of GN patients bind similar amounts of labeled GBM antigens to anti-GBM serum antibodies.
The method of extraction and purification of ['I]GBM Ag might modify some of the antigenic determinants present in intact GBM. However, GBM antigens used always carry antigenic determinants accessible in vivo on the whole GBM structure, since immunoglobulins eluted from Goodpasture's syndrome kidneys bind these ['NJI]GBM Ag. Finally, the reproducibility of the radioimmunoassay is quite comparable to that reported for other radioimmunoassay systems (35) , and it is more sensitive than indirect immunofluorescence or passive hemagglutination. It appears, therefore, that this direct binding test is a sensitive and quantitative method for detection of circulating anti-GBM antibodies in patients with GN and linear deposits of immunoglobulins.
The existence of circulating anti-GBM antibodies in a few cases of proliferative GN and granular deposits of immunoglobulins confirms previous results obtained with the passive hemagglutination test (6) . By radioimmunoassay, it has been further demonstrated that IgG fractions isolated from these positive sera bind the GBM antigens. Binding tests performed in patients without proliferative GN are negative. The GBM binding activity observed in the serum of some cases of proliferative GN with granular deposits is always lower than that observed in GN with linear deposits. The role of circulating anti-GBM antibodies detected in proliferative GN without linear deposits remains questionable. The presence of granular IgG deposits and the low concentration of these antibodies are not in favor of a major role of such antibodies in the pathogenesis of these types of nephritis. However, it is possible that these antibodies react in vivo with GBM antigenic determinants normally hidden inside the GBM structure. Such complexes might be formed in situ on altered GBM or might result from a release of such antigens in the circulation, as in the autologous immune complex nephritis (36) .
